XT
KRSA

XTX Topco’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

XTX Topco’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,432
Closed -$12.7K – 3926
2025
Q4 		$12.7K Buy
+1,432
New +$2.56K ﹤0.01% 3145
2021
Q4 		– Sell
-74
Closed -$32K – 746
2021
Q3 		$32K Sell
74
-54
-42% -$3.53K 0.01% 629
2021
Q2 		$70K Buy
128
+33
+35% +$2.07K 0.02% 697
2021
Q1 		$37K Buy
+95
New +$7.14K 0.02% 639

Other funds holding KRSA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

XTX Topco's KRSA Position: Q1 2026 in Review

XTX Topco sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q1 2026, closing a stake of 1,432 shares — an estimated $12.7K sold.

XTX Topco first reported a position in KRSA in Q1 2021 and held it in 4 quarters. The position peaked at $70K in Q2 2021. 16 funds tracked by Wall St. Rank hold KRSA as of Q1 2026.

  • XTX Topco reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 1,432 Korsana Biosciences, Inc. Common Stock shares in Q1 2026, an estimated $12.7K.
  • XTX Topco first reported a position in Korsana Biosciences, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • XTX Topco's Korsana Biosciences, Inc. Common Stock position peaked at $70K in Q2 2021.
  • 16 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.